The new Eurosurveillance website is almost here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Further content
Skip Navigation LinksEurosurveillance About us


About us

Eurosurveillance is a European peer-reviewed scientific journal devoted to the epidemiology, surveillance, prevention and control of communicable diseases, with a focus on such topics that are of relevance to Europe. It is a weekly online journal, with 50 issues per year published on Thursdays, and features short rapid communications, longer in-depth research articles, surveillance and outbreak reports, reviews and perspective papers, as well as short news items. Timely publication of short authoritative papers on ongoing outbreaks or other relevant public health events is one of the major assets of the journal. Under special circumstances when current events need to be urgently communicated to readers for rapid public health action, e-alerts can be released outside of the regular publishing schedule. Topical compilations of selected articles and special issues are also published in print.

The entire content is open access, free of charge for both readers and authors. All articles are indexed in the PubMed/MEDLINE, Scopus, EMBASE and EBSCO databases. In 2015, Eurosurveillance reapplied successfully to be listed in the Directory of Open Access Journals (DOAJ) and is listed in the Sherpa/Romeo database as a journal that complies with the open access standards required by funders such as the Wellcome Trust.
The journal has been selected for coverage by Thomson Reuters and is indexed and abstracted in the Science Citation Index Expanded (also known as SciSearch) and in the Journal Citation Reports/Science Edition beginning with volume 14(1) 2009. The current impact factor, for the year 2015, is 5.98 (Journal Citation Reports, Thomson Reuters, 2016). This places Eurosurveillance at rank 7 among the 83 journals in the category Infectious Diseases. The Scopus-based SCImago Journal Rank (SJR) for 2014 ranks Eurosurveillance 92 of 1,775 journals in the category Medicine. The journal is also in the first quarter (Q1) in the categories Epidemiology, Public Health, Environmental and Occupational Health and Virology. Google Scholar metrics in mid-2014 listed Eurosurveillance at ranks 4 and 10 among journals in the categories Epidemiology and Communicable Diseases.

Approximately 11,700 active subscribers receive the weekly table of contents via email. In 2014, 68 peer-reviewed rapid communications and 137 peer-reviewed long articles were published in Eurosurveillance, by authors from ca 60 countries worldwide, as well as 83 editorials, news pieces, letters and meeting reports. The rejection rate was ca 80%. All articles since 1995 are available on the Eurosurveillance website.

Eurosurveillance was founded in 1995 and jointly funded until March 2007 by the European Commission, the Institut de Veille Sanitaire (InVS) in Paris, France and the Health Protection Agency (HPA) in London, United Kingdom. Eurosurveillance is a registered trademark of the European Union (EU). Since March 2007, Eurosurveillance has been published by the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden. ECDC funds this web site with its own resources; Eurosurveillance does not have any other sources of funding. The publisher grants editorial independence to the editorial team ( The views expressed in the journal are those of the authors and may not necessarily comply with ECDC policy. As a non-profit publication, the journal has no financial conflicts of interest.

In January 2010, Eurosurveillance was accredited by the Health on the Net (HON) Foundation as adhering to the HON code of conduct (HONcode). HON is a non-governmental, non-profit organisation with the purpose of supporting users to identify sound, reliable and trustworthy health information on the Internet since 1995.

The editorial team is based in Stockholm, and supported by a board of 17 Associate editors and currently 39 country advisors. The Associate editors consist of internationally renowned and active experts in the fields of public health and clinical medicine with expertise in infectious diseases, laboratory research and diagnostics and mathematical modelling. Our editorial advisors serve as contacts in the 28 Member States as well as Norway and the EU candidate and potential candidate countries, and help us maintain close ties to our authors and reviewers. The editorial board meets in person once a year but also provides ongoing advice through our extranet. Board members serve for a period of three years which can be extended.

EDITORIAL TEAM To the topTo top

Dr Ines Steffens MD, MPH and DTM&PH

Senior editor
Kathrin Hagmaier, PhD

Scientific editors
Karen Wilson, PhD
Janelle Sandberg

Assistant editors
Alina Buzdugan, BA
Ingela Rumenius, BEc, MA
Vilasini Roy

Dragos Platon, Fabrice Donguy

Technical support
ECDC ICT services

Contact the editorial team at:


Tommi Asikainen, The Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium

Magnus Boman, Royal Institute of Technology (KTH), Stockholm, Sweden

Mike Catchpole, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Denis Coulombier, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Natasha Crowcroft, Public Health Ontario and University of Toronto, Toronto, Canada

Christian Drosten, University of Bonn Medical Centre, Bonn, Germany

Karl Ekdahl, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Johan Giesecke, Karolinska Institute, Stockholm, Sweden

David Heymann, Public Health England and London School of Hygiene & Tropical Medicine, London, United Kingdom

Heath Kelly, Victorian Infectious Disease Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne and Australian National University, Canberra, Australia

Irena Klavs, National Institute of Public Health, Ljubljana, Slovenia

Karl Kristinsson, Landspitali University Hospital, Reykjavik, Iceland

Daniel Lévy-Bruhl, Santé publique France, Paris, France

Jacob Moran-Gilad, Ministry of Health, Jerusalem and Ben-Gurion University of the Negev, Beer-Sheva, Israel

Panayotis T. Tassios, National & Kapodistrian University of Athens, Athens, Greece

Hélène Therre, Santé publique France, Paris, France

Henriette de Valk, Santé publique France, Paris, France

Sylvie van der Werf, Pasteur Institute and University Paris Diderot, Paris, France



Albania: Alban Ylli, Department of Epidemiology and Health Systems, Institute of Public Health, Tirana

Austria: Maria Paulke-Korinek, Ministry of Health and Women’s Affairs, Vienna

Belgium: Koen de Schrijver, Flemish Agency of Public Health, Antwerp and Tinne Lernout, Scientific Institute of Public Health, Brussels

Bosnia and Herzegovina: Sanjin Musa, Ministry of Health of the Federation of Bosnia and Herzegovina, Sarajevo

Bulgaria: Iva Christova, National Center of Infectious and Parasitic Diseases, Sofia

Croatia: Sanja Music Milanovic, Croatian National Institute of Public Health, Zagreb

Cyprus: Maria Koliou, Directorate of Medical and Public Health Services, Nicosia

Czech Republic: Jan Kynčl, National Institute of Public Health, Prague

Denmark: Peter Henrik Andersen, Statens Serum Institut, Copenhagen

Estonia: Kuulo Kutsar, Health Board, Tallinn

Finland: Outi Lyytikäinen, National Institute for Health and Welfare, Helsinki

France: Judith Benrekassa, Santé Publique France, Paris

Germany: Jamela Seedat, Robert Koch Institute, Berlin

Greece: Rengina Vorou, Hellenic Center for Diseases Control and Prevention, Athens

Hungary: Ágnes Hajdu, National Center for Epidemiology, Budapest

Iceland: Gudrun Sigmundsdottir, Directorate of Health, Reykjavik

Ireland: Lelia Thornton, Health Protection Surveillance Centre, Dublin

Italy: Paola De Castro, Istituto Superiore di Sanità, Rome

Kosovo under UN Security Council Resolution 1244: to be confirmed

Latvia: Dzintars Mozgis, Centre for Disease Prevention and Control, Riga

Lithuania: Saulius Caplinskas

Luxembourg: Thérèse Staub, Centre Hospitalier de Luxembourg, Luxembourg

The former Yugoslav Republic of Macedonia: Aziz Pollozhani, Institute for Public Health of Republic of Macedonia, Skopje

Malta: Tanya Melillo Fenech, Superintendence of Public Health, Ministry of Health, The Elderly and Community Care, Msida

Montenegro:Senad Begić, Institute for Public Health of Montenegro, Podgorica

Netherlands: Danielle Nijsten, RIVM National Institute for Public Health and the Environment, Bilthoven

Norway: to be confirmed

Poland: Malgorzata Sadkowska-Todys, National Institute of Public Health – National Institute of Hygiene, Warsaw

Portugal: Paulo Jorge Nogueira, Directorate General of Health, Lisbon

Romania: Daniela Pitigoi, National Institute for Infectious Diseases "Prof.Dr.Matei Bals", Bucharest

Serbia: Mijomir Pelemis, Serbian Society for antimicrobial chemotherapy, Belgrade

Slovakia: Lukáš Murajda, Public Health Authority of the Slovak Republic, Bratislava

Slovenia: Maja Sočan, National Institute of Public Health, Ljubljana

Spain: Rosa Cano Portero, National Centre of Epidemiology, Instituto de Salud Carlos III, Madrid

Sweden: Anders Wallensten, Folkhälsomyndigheten, Stockholm

Turkey: Fehminaz Temel, Public Health Institution of Turkey, Ankara

United Kingdom: Nick Phin, Public Health England, London

World Health Organization Regional Office for Europe: Robb Butler, World Health Organization (Regional Office for Europe), Copenhagen, Denmark

To receive our electronic Table of contents click here to subscribe .

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.